a polysaccharide antigen (from, for example, tetanus or diphtheria) chemically joined with a recombinant protein for increased vaccine immunogenicity; conjugate vaccines in the childhood immunization program are Hib and MenC.
A vaccine in which a polysaccharide antigen is chemically joined with a protein molecule to improve the immunogenicity of the polysaccharide.
Vaccines utilising purified carbohydrates (polysaccharides) from a bacterial capsule linked to protein carriers to improve the immune stimulatory effect.
The joining together of two compounds (usually a protein and polysaccharide) to increase a vaccine's effectiveness.
a vaccine in which a part of the germ is combined with a protein which makes it work better and gives better protection over a long period of time. Examples of conjugate vaccines include tetanus and diptheria.
A type of vaccine made from the polysaccharide (sugar) of a bacterium joined to a protein carrier. This type of vaccine gives a better immune response in infants and young children.
These vaccines are made with part of the germ which is combined with a protein (e.g. tetanus or diphtheria) which makes it work better and gives better protection over a long period of time. The conjugate vaccines in the childhood immunisation schedule are Hib and Men C.
A conjugate vaccine is created by covalently attaching a poor antigen to a carrier protein, thereby conferring the immunological attributes of the carrier on the attached antigen. This technique for the creation of an effective immunogen is most often applied to bacterial polysaccharides for the prevention of invasive bacterial disease.